Drug profile · INN
protriptyline hydrochloride
VIVACTIL
protriptyline hydrochloride (VIVACTIL) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — protriptyline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
protriptyline hydrochloride (VIVACTIL) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is protriptyline hydrochloride?
protriptyline hydrochloride (VIVACTIL) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for protriptyline hydrochloride?
VIVACTIL is a marketed brand name for protriptyline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of protriptyline hydrochloride?
protriptyline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.